Fbw7 dimerization determines the specificity and robustness of substrate degradation

  1. Bruce E. Clurman1,2,8
  1. 1Clinical Research Division,
  2. 2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA;
  3. 3MCB Program, University of Washington, Seattle, Washington 98195, USA;
  4. 4Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland;
  5. 5Howard Hughes Medical Institute,
  6. 6Department of Pharmacology, University of Washington, Seattle, Washington 98195, USA
    1. 7 These authors contributed equally to this work.

    Abstract

    The Fbw7 tumor suppressor targets a broad network of proteins for ubiquitylation. Here we show critical functions for Fbw7 dimerization in regulating the specificity and robustness of degradation. Dimerization enables Fbw7 to target substrates through concerted binding to two suboptimal and independent recognition sites. Accordingly, an endogenous dimerization-deficient Fbw7 mutation stabilizes suboptimal substrates. Dimerization increases Fbw7's robustness by preserving its function in the setting of mutations that disable Fbw7 monomers, thereby buffering against pathogenic mutations. Finally, dimerization regulates Fbw7 stability, and this likely involves Fbw7 trans-autoubiquitylation. Our study reveals novel functions of Fbw7 dimerization and an unanticipated complexity in substrate degradation.

    Keywords

    Footnotes

    • Received August 21, 2013.
    • Accepted October 29, 2013.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.

    | Table of Contents

    Life Science Alliance